Co-founder and President of Cibiltech, Stephane has 12 years of entrepreneurial experience in marketing and application development for research and innovation players (R&D departments of large groups, laboratories, startups). After graduating in chemistry (MSc UPMC 2008) and management (ESCP 2009), Stephane created his first company in 2009 (Umaps - agency specialized in innovative marketing) and his second in 2012 (Bluenod - SaaS software for complex data visualization). In 2017, he started working on the creation of Cibiltech with Alexandre Loupy, world key opinion leader in kidney transplantation and inventor of the iBox algorithm.
Co-Founder and Scientific Director at Cibiltech, Doctor-Researcher, Olivier defended his PhD in medical science in 2014 and was awarded the Paris Hospital Residents' Prize. He also defended his PhD in biostatistics and epidemiology in 2017 at the Paris Center for Translational Science on Organ Transplantation. His research focuses on kidney transplant allocation criteria, transplantation of kidneys from donors meeting expanded criteria, and risk stratification using machine learning and multidimensional algorithms integrating antibody-mediated kidney transplant rejection data and the relationship with histological graft damage, molecular phenotypes and allograft outcome.
Graduated from the École Polytechnique and with a master's degree from the École Nationale des Mines, Helene started her professional career in 2009 at General Electric Healthcare, then at Sorin CRM. In 2012 she joined Humanis, one of the largest French mutual insurance groups, before moving to England for 5 years where she became Chief Operating Officer at Cupris, then CEO of Bioinduction in 2018. Given her solid experience in the healthcare field and a strong interest for innovation, Helene joined Cibiltech in 2020 as COO.
Manon first joined Cibiltech during her internship as part of her MBA at IONIS School of Technology and Management in 2019 and was hired in 2020. Quickly integrated into the team, Manon showed interest in a variety of missions and processes she participated in executing and improving. Result-driven, organized, efficient, and empathetic, Manon's contribution is essential to achieve a strong Quality System that meets the requirements of the healthcare industry.
Co-founder and CTO at Cibiltech, Mikaly is a graduate engineer from ENSEA and has more than 12 years of experience in the development of IT solutions in health and biotechnology. At Cibiltech, Mikaly leads the development of the company's technical platform and SaaS solutions for healthcare teams involved in the management of transplanted patients and clinical studies conducted by Cibiltech and its partners.
Winner of the Grand Prix de l'Innovation from Paris in the e-health category, Cibiltech develops a digital platform that revolutionises medical practices in kidney transplantation thanks to a predictive algorithm. Our AI-based technology enables nephrologists to evaluate the probabilities of kidney transplant loss for each patient. This personalised follow-up treatment allows doctors to adapt treatments accordingly in order to prolong the survival of the kidney grafts. Patients can live better and longer. Financial resources for hospitals and health systems can be optimised.
Cibiltech wishes to hire technical talents to support the development of its SaaS solutions. The company is also looking for sales and marketing profiles specialized in the medical field.
- Pioneers in predictive medicine
- Worldwide scientific recognition of the founders
- An international work environment
- A dynamic team who loves sports but also croissants and chocolate.
- Regular yoga sessions and team activities every Thursday.
- Regular internal training to enrich your knowledge